SARS-CoV-2 ORF7a Protein

Produktnummer ABIN7321316

Produktdetails

Target: SARS-CoV-2 ORF7a

Protein-Typ: Recombinant

Spezies: SARS Coronavirus-2 (SARS-CoV-2)

Quelle: Escherichia coli (E. coli)

Verwendungszweck: Recombinant SARS-CoV-2 ORF7a protein

Sequenz: Glu16-Tyr97

Produktmerkmale: Recombinant SARS-CoV-2 ORF7a protein is produced by E.coli expression system and the target gene encoding Glu16-Tyr97 is expressed with N-His Tag

Reinheit: >90 % as determined by SDS-PAGE

Biological Activity Comment: Test in progress

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Please refer to the printed manual for detailed information.

Buffer: Supplied as solution form in PBS, pH 7.5 or lyophilized from PBS, pH 7.5

Lagerung: 4 °C,-20 °C,-80 °C

Informationen zur Lagerung: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.

Antigendetails

Target: SARS-CoV-2 ORF7a

Abstract: SARS-CoV-2 ORF7a Produkte

Synonyme: ORF7a protein Protein, ORF7a Protein

Substanzklasse: Viral Protein

Hintergrund:

Background: Plays a role as antagonist of host tetherin (BST2), disrupting its antiviral effect. Acts by binding to BST2 thereby interfering with its glycosylation. May suppress small interfering RNA (siRNA). May bind to host ITGAL, thereby playing a role in attachment or modulation of leukocytes.

Synonym: Accessory protein 7a,Protein U122,Protein X4,7a

Molekulargewicht: 12.07kDa